ATC Group: A03CA02 Clidinium and psycholeptics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03CA02 in the ATC hierarchy

Level	Code	Title
`1`	A	Alimentary tract and metabolism
`2`	A03	Drugs for functional gastrointestinal disorders
`3`	A03C	Antispasmodics in combination with psycholeptics
`4`	A03CA	Synthetic anticholinergic agents in combination with psycholeptics
`5`	A03CA02	Clidinium and psycholeptics

Active ingredients in A03CA02

Active Ingredient
Clidinium
Clidinium is a synthetic anticholinergic that has a spasmolytic effect on smooth muscle and also inhibits secretions.

Related product monographs

Document	Type	Information Source
LIBRAX Capsule	MPI, CA: SPM	Health Products and Food Branch (CA)

United States medicines

(combination) LIBRAX

Medicines classified under this ATC code globally

Canada (CA)

(combination) CHLORAX
(combination) LIBRAX

Cyprus (CY)

(combination) BRALIX
(combination) LIBRAX

Ecuador (EC)

(combination) LEMBIRAX

Finland (FI)

(combination) LIBRAX

France (FR)

(combination) LIBRAX

Hong Kong (HK)

(combination) MEDOCALUM

Singapore (SG)

(combination) CHLOBAX

Tunisia (TN)

(combination) LIBRAX

Turkey (TR)

(combination) LIBRAX

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Go to ATC index